€42.48
0.70% yesterday
Helsinki, Dec 23, 04:51 pm CET
ISIN
FI0009014377
Symbol
ORNBV
Sector
Industry

Orion Stock price

€42.44
-3.19 6.99% 1M
+2.43 6.07% 6M
+3.17 8.07% YTD
+3.17 8.07% 1Y
+6.60 18.42% 3Y
+0.77 1.85% 5Y
+16.03 60.72% 10Y
Helsinki, Closing price Mon, Dec 23 2024
-0.34 0.79%
ISIN
FI0009014377
Symbol
ORNBV
Sector
Industry

Key metrics

Market capitalization €5.96b
Enterprise Value €6.03b
P/E (TTM) P/E ratio 17.97
EV/FCF (TTM) EV/FCF 31.24
EV/Sales (TTM) EV/Sales 4.22
P/S ratio (TTM) P/S ratio 4.17
P/B ratio (TTM) P/B ratio 6.45
Dividend yield 3.82%
Last dividend (FY24) €1.62
Revenue growth (TTM) Revenue growth 22.68%
Revenue (TTM) Revenue €1.43b
EBIT (operating result TTM) EBIT €374.30m
Free Cash Flow (TTM) Free Cash Flow €193.00m
Cash position €190.10m
EPS (TTM) EPS €2.36
P/E forward 19.59
P/S forward 4.00
EV/Sales forward 4.05
Show more

Is Orion a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.

Orion Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Orion forecast:

5x Buy
71%
1x Hold
14%
1x Sell
14%

Analyst Opinions

7 Analysts have issued a Orion forecast:

Buy
71%
Hold
14%
Sell
14%

Financial data from Orion

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,429 1,429
23% 23%
100%
- Direct Costs 573 573
9% 9%
40%
856 856
34% 34%
60%
- Selling and Administrative Expenses 276 276
14% 14%
19%
- Research and Development Expense 154 154
19% 19%
11%
426 426
60% 60%
30%
- Depreciation and Amortization 52 52
1% 1%
4%
EBIT (Operating Income) EBIT 374 374
74% 74%
26%
Net Profit 332 332
91% 91%
23%

In millions EUR.

Don't miss a Thing! We will send you all news about Orion directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland.

Head office Finland
CEO Aino Hurme
Employees 3,632
Founded 1917
Website www.orion.fi

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today